Grifols is a pharmaceutical company based in Spain that makes medicines from human blood plasma. It collects plasma at its own donation centres and processes it into therapies such as immunoglobulins, albumin and clotting factor products, which are used to treat immune deficiencies, bleeding disorders and other conditions. Its customers are mainly hospitals, clinics and healthcare systems, and it also supplies diagnostic instruments and services for blood testing in laboratories and transfusion centres.
Grifols S.A. trades under the code 0RDU on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2061 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendFair
57/100
Mixed trend against its averages.
See the numbers →
Above 200-day average3.1%
From 52-week high-13.7%
MomentumFair
53/100
Typical recent returns for this exchange.
See the numbers →
3-month return2.7%
6-month return9.9%
12-month, skipping last month-14.1%
Stability (higher is calmer)Fair
63/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)28.4%
Worst drawdown, 1 year (smaller is calmer)-25.3%
LiquidityWeak
39/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.25M EUR
Zero-volume days0.0%
IncomeWeak
6/100
Dividend is small or irregular.
See the numbers →
Dividend yield0.7%
Years with dividends2
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 8.449 – 11.695Daily closes, split-adjusted
Signals
50-day average9.837
200-day average9.689
Golden/death cross (60d)Golden, 23 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.215
Technical summary
Daily
Strongly bullish
11 bullish · 4 neutral · 1 bearish
Weekly
Bullish
8 bullish · 1 neutral · 3 bearish
Monthly
Neutral
3 bullish · 1 neutral · 4 bearish
Moving averages (daily)
SMA 10
10.01
Bearish
EMA 10
9.99
Bullish
SMA 20
9.85
Bullish
EMA 20
9.90
Bullish
SMA 50
9.84
Bullish
EMA 50
9.81
Bullish
SMA 100
9.59
Bullish
EMA 100
9.72
Bullish
SMA 200
9.69
Bullish
EMA 200
9.80
Bullish
Oscillators (daily)
RSI (14)
53.75
Neutral
MACD (12, 26)
0.09
Bullish
Momentum (12)
1.44
Bullish
Stochastic %K (14)
72.58
Neutral
Williams %R (14)
-27.42
Neutral
CCI (20)
84.92
Neutral
Pivot points (classic, last session)
S3
9.79
S2
9.89
S1
9.94
Pivot
10.04
R1
10.09
R2
10.19
R3
10.24
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.07 EUR
Yield on today's price
0.67%
Frequency
Annual
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.0667
0.1215
0.2951
0.1309
0.1620
0.1176
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
